{"prompt": "['ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY', 'ALLIANCE A171601', 'A PHASE II TRIAL ASSESSING THE TOLERABILITY OFPALBOCICLIB IN COMBINATION WITH', 'LETROZOLE OR FULVESTRANT IN PATIENTS AGED 70 AND OLDER WITH ESTROGEN RECEPTOR-', 'POSITIVE, HER2-NEGATIVE METASTATIC BREAST CANCER', 'Commercial agent(s): Palbociclib; (IND: exempt)', 'ClinicalTrials.gov Identifier: NCT03633331.', 'Study Chair', 'Mina S. Sedrak MD, MS', 'City of Hope Comprehensive Cancer Center', 'Study Co-Chair', 'Aminah Jatoi MD', 'Mayo Clinic', 'Community Oncology Co-Chair', 'Correlative Study Co-Chair Pharmacogenomics Study Co-Chair', 'Imaging Co-Chair', 'Pharmacokinetics Study Co-Chair', 'Breast Committee Study Co-Chair', 'Study Co-Chair', 'Cancer in the Elderly Committee Co-Chairs', 'Breast Committee Co-Chairs', 'Primary Statistician', 'Secondary Statistician', 'Data Manager', 'Protocol Coordinator', 'In memory of Dr. Arti Hurria', 'Participating NCTN Groups:', 'Alliance/Alliance for Clinical Trials in Oncology (lead), ECOG-ACRIN/ECOG ACRIN Cancer Research Group,', 'NRG/NRG Oncology, SWOG/ SWOG', '1', 'NCIVersion Date: 5/29/2020', 'Update 5']['Alliance A171601', 'Study Resources:', 'Expedited Adverse Event Reporting', 'Medidata Rave\u00ae iMedidata portal', 'OPEN (Oncology Patient Enrollment Network)', 'Biospecimen Management System', 'Protocol Contacts:', 'A171601 Nursing Contact', 'A171601 Pharmacy Contact', 'IROC', 'Alliance Biorepository at Mayo Clinic', 'University of Pittsburgh Cancer Institute', 'Protocol-related questions may be directed as follows:', 'Questions', 'Contact (via email)', 'Questions regarding patient eligibility, treatment,', 'Study Chair, Nursing Contact, Protocol', 'and dose modification:', 'Coordinator, and (where applicable) Data Manager', 'Questions related to data submission, RAVE or', 'Data Manager', 'patient follow-up:', 'Questions regarding the protocol document and', 'Protocol Coordinator', 'model informed consent:', 'Questions related to IRB review', 'Alliance Regulatory Inbox', 'Questions regarding CTEP-AERS reporting:', 'Alliance Pharmacovigilance Inbox', 'Questions regarding specimens/specimen', 'submissions:', 'Appropriate Alliance Biorepository', 'Questions regarding drug administration', 'Pharmacy Contact', '2', 'NCI Version Date: 5/29/2020', 'Update 5']['Alliance A171601', 'CANCER TRIALS SUPPORT UNIT (CTSU) ADDRESS AND CONTACT INFORMATION', 'For regulatory requirements:', 'For patient enrollments:', 'For data submission:', 'Regulatory documentation must', 'Refer to the patient enrollment', 'Data collection for this study will', 'be submitted to the CTSU via', 'section of the protocol for', 'be done exclusively through', 'the Regulatory Submission', 'instructions on using the', 'Medidata Rave. Refer to the data', 'Portal.', 'Oncology Patient Enrollment', 'submission section of the protocol', 'Network (OPEN). OPEN is', 'for further instructions.', '(Sign in at', 'and', 'accessed at', 'select the Regulatory >', 'Regulatory Submission.)', 'Do not submit study data or forms', 'to the CTSU. Do not copy the', 'Institutions with patients', 'CTSU on data submissions.', 'waiting that are unable to use', 'Contact the CTSU Help Desk', 'the Portal should alert the', 'with any OPEN-related', 'CTSU Regulatory Office', 'questions by phone or email :', 'immediately at', 'or', 'to receive further instruction', '.', 'and support.', 'Contact the CTSURegulatory', 'Help Desk at', 'for regulatory assistance.', 'The most current version of the study protocol and all supporting documents must be downloaded', \"from the protocol-specific page located on the CTSU members' website\", 'Access', \"to the CTSU members' website is managed through the Cancer Therapy and Evaluation Program -\", 'Identity and Access Management (CTEP-IAM) registration system and requires log in with a CTEP-', 'IAM username and password', 'Permission to view and download this protocol and its supporting documents is restricted and is based', 'on person and site roster assignment housed in the CTSU Regulatory Support System (RSS).', 'Institutions will order the following supplies from the CTSU Operations Office: Questionnaire booklets.', 'Supplies can be ordered by downloading and completing the CTSU Supply Request Form (available on', 'the protocol-specific page on the CTSU website) and submitting it as instructed on the form.', 'For clinical questions (i.e., patient eligibility or treatment-related) see the Protocol Contacts, Page 2.', 'For non-clinical questions (i.e., unrelated to patient eligibility, treatment, or clinical data', 'submission) contact the CTSUHelp Desk by phone or email:', 'CTSU General Information Line -', 'or', '.', 'All calls and', 'correspondence will be triaged to the appropriate CTSU representative.', '3', 'NCIVersion Date: 5/29/2020', 'Update 5']\n\n###\n\n", "completion": "END"}